Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Respiratory SystemDRG 206-other-respiratory-system-diagnoses-without-mcc
    Ask Trek AI about this page

    Other Respiratory System Diagnoses without MCC: Inpatient Reimbursement Overview

    DRG 206 encompasses other respiratory system diagnoses without a Major Complication or Comorbidity, covering lower-severity inpatient respiratory admissions such as uncomplicated pneumonia and bronchitis. It matters for inpatient reimbursement because it standardizes payment for cases with moderate resource use under the Centers for Medicare & Medicaid Services prospective payment framework.

    Customize your policy alerts

    Sign up for drg 206 policy alerts

    Get alerted when payer policies referencing 206 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 206 Overview

    DRG 206 covers inpatient admissions for a range of noncritical respiratory diagnoses that do not involve a Major Complication or Comorbidity and that do not require intensive resource use. Typical cases include uncomplicated pneumonia, bronchitis, asthma exacerbations, and other respiratory conditions managed with standard inpatient care. This Diagnosis-Related Group matters for Medicare payment because it groups patients with similar clinical complexity and expected resource consumption, which determines hospital reimbursement under the Medicare inpatient prospective payment system. Understanding this category helps clarify payment expectations for common, lower-severity respiratory admissions.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute inpatient management trials evaluating short-term interventions for non-specific or heterogeneous respiratory diagnoses (for example, studies assessing oxygen delivery strategies, timing of corticosteroid use, or escalation protocols for respiratory support). These trials typically enroll adults hospitalized for acute respiratory symptoms or diagnoses that do not meet criteria for major complications or comorbidities (the population captured by this DRG) and focus on immediate physiologic or safety endpoints such as time to clinical stability, avoidance of intubation, or length of stay. Results are directly relevant to hospital clinicians and payers because optimized acute protocols can reduce utilization, prevent escalation to higher-cost DRGs, and improve throughput for a broadly varied respiratory cohort.
    • Comparative effectiveness studies comparing diagnostic and management pathways for heterogeneous respiratory presentations (for example, protocols that compare algorithm-driven imaging and biomarker use versus usual care, or early targeted outpatient versus continued inpatient observation strategies). These studies enroll the diverse group of patients with respiratory diagnoses that lack major complications and aim to determine which approaches best balance diagnostic yield, treatment initiation, and resource use. Findings inform clinicians and payers about which pathways safely reduce unnecessary testing, shorten hospital stays, and allocate resources efficiently across a population that otherwise generates variable utilization.
    • Post-discharge outcomes and care-transition research focusing on readmission prevention, rehabilitation, and outpatient follow-up strategies for patients discharged with residual respiratory symptoms or functional limitations. These cohort studies or pragmatic trials assess interventions such as structured discharge education, home oxygen monitoring, telehealth follow-up, or pulmonary rehabilitation referral among patients previously hospitalized under this DRG to measure 30- and 90-day readmissions, functional recovery, and downstream costs. Such research matters to providers and payers because effective post-discharge interventions can lower readmission rates, improve patient-centered outcomes, and reduce cumulative cost of care in this common, heterogeneous inpatient group.

    Related Codes

    163-MAJOR-CHEST-PROCEDURES-WITH-MCC

    Major Chest Procedures with MCC: Inpatient Reimbursement Overview

    164-MAJOR-CHEST-PROCEDURES-WITH-CC

    Major Chest Procedures with CC: Inpatient Reimbursement Overview

    165-MAJOR-CHEST-PROCEDURES-WITHOUT-CC-MCC

    Major Chest Procedures without CC/MCC: Inpatient Reimbursement Overview

    166-OTHER-RESPIRATORY-SYSTEM-O-R-PROCEDURES-WITH-MCC

    Other Respiratory System O.R. Procedures with MCC: Inpatient Reimbursement Overview

    167-OTHER-RESPIRATORY-SYSTEM-O-R-PROCEDURES-WITH-CC

    Other Respiratory System O.R. Procedures with CC: Inpatient Reimbursement Overview

    168-OTHER-RESPIRATORY-SYSTEM-O-R-PROCEDURES-WITHOUT-CC-MCC

    Other Respiratory System O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview

    173-ULTRASOUND-ACCELERATED-AND-OTHER-THROMBOLYSIS-WITH-PRINCIPAL-DIAGNOSIS-PULMONARY-EMBOLISM

    Ultrasound Accelerated and Other Thrombolysis with Principal Diagnosis Pulmonary Embolism: Inpatient Reimbursement Overview

    175-PULMONARY-EMBOLISM-WITH-MCC-OR-ACUTE-COR-PULMONALE

    Pulmonary Embolism with MCC or Acute Cor Pulmonale: Inpatient Reimbursement Overview

    176-PULMONARY-EMBOLISM-WITHOUT-MCC

    Pulmonary Embolism without MCC: Inpatient Reimbursement Overview

    177-RESPIRATORY-INFECTIONS-AND-INFLAMMATIONS-WITH-MCC

    Respiratory Infections and Inflammations with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 40

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.